176911-83-4

Basic information

• Product Name: (2R,3R,4S,5R,6S)-3,4,5-Tris-benzyloxy-2-(4-nitro-benzyloxymethyl)-6-((S)-1-oxiranylmethoxy)-tetrahydro-pyran
• Synonyms: (2R,3R,4S,5R,6S)-3,4,5-Tris-benzyloxy-2-(4-nitro-benzyloxymethyl)-6-((S)-1-oxiranylmethoxy)-tetrahydro-pyran
• CAS NO: 176911-83-4
• Molecular Weight: 641.718
• Mol File: 176911-83-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2R,3R,4S,5R,6S)-3,4,5-Tris-benzyloxy-2-(4-nitro-benzyloxymethyl)-6-((S)-1-oxiranylmethoxy)-tetrahydro-pyran(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3R,4S,5R,6S)-3,4,5-Tris-benzyloxy-2-(4-nitro-benzyloxymethyl)-6-((S)-1-oxiranylmethoxy)-tetrahydro-pyran(176911-83-4)
• EPA Substance Registry System: (2R,3R,4S,5R,6S)-3,4,5-Tris-benzyloxy-2-(4-nitro-benzyloxymethyl)-6-((S)-1-oxiranylmethoxy)-tetrahydro-pyran(176911-83-4)

Safety Data

• Hazardous Substances Data: 176911-83-4(Hazardous Substances Data)

Upstream product

• 39483-53-9 2,3,4-tri-O-benzyl-6-O-p-nitrobenzoyl-α-D-glucopyranosyl bromide 
• 60456-23-7 (S)-oxiranemethanol 

Downstream Products

• 158227-72-6 Hexadecanoic acid (S)-1-hexadecanoyloxymethyl-2-{(2S,3R,4S,5R,6R)-3,4,5-tris-benzyloxy-6-[(2-bromo-ethoxy)-hydroxy-phosphoryloxymethyl]-tetrahydro-pyran-2-yloxy}-ethyl ester 
• 158227-70-4 Hexadecanoic acid (S)-1-hexadecanoyloxymethyl-2-[(2S,3R,4S,5R,6R)-3,4,5-tris-benzyloxy-6-(tert-butyl-dimethyl-silanyloxymethyl)-tetrahydro-pyran-2-yloxy]-ethyl ester 
• 158227-71-5 Hexadecanoic acid (S)-1-hexadecanoyloxymethyl-2-((2S,3R,4S,5R,6R)-3,4,5-tris-benzyloxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-ethyl ester 
• 158227-69-1 Hexadecanoic acid (S)-2-hydroxy-3-((2S,3R,4S,5R,6R)-3,4,5-tris-benzyloxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-propyl ester 

Relevant articles and documents

Synthesis and absolute configuration of 6-O-phosphocholine-α-D-glucopyranosyl glycerolipid isolated from HTLV-I-infected cell lines

Syntheses of both stereoisomers of α-D-glucopyranosylglycerolipids enabled us to confirm the structure and the (2S)-configuration of a new glycoglycerolipid isolated from HTLV-I infected T-cell lines.